These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 3200240)
61. Splenic Doppler impedance indices: influence of different portal hemodynamic conditions. Bolognesi M; Sacerdoti D; Merkel C; Gerunda G; Maffei-Faccioli A; Angeli P; Jemmolo RM; Bombonato G; Gatta A Hepatology; 1996 May; 23(5):1035-40. PubMed ID: 8621130 [TBL] [Abstract][Full Text] [Related]
62. Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics. Lee FY; Lin HC; Tsai YT; Chang FY; Lu RH; Hou MC; Li CP; Chu CJ; Wang SS; Lee SD Am J Gastroenterol; 1997 Nov; 92(11):2080-4. PubMed ID: 9362197 [TBL] [Abstract][Full Text] [Related]
63. [Studies on systemic hemodynamics and sympathetic nervous activity in portal hypertension]. Nikkuni K Nihon Geka Gakkai Zasshi; 1988 Oct; 89(10):1672-85. PubMed ID: 3200240 [TBL] [Abstract][Full Text] [Related]
65. Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension. Reichen J Hepatology; 1990 Jun; 11(6):1066-78. PubMed ID: 2194921 [No Abstract] [Full Text] [Related]
66. The endocannabinoid system and its role in the pathogenesis and treatment of cardiovascular disturbances in cirrhosis. Măries L; Manitiu I Acta Gastroenterol Belg; 2013 Jun; 76(2):195-9. PubMed ID: 23898556 [TBL] [Abstract][Full Text] [Related]
67. Aspects of sympathetic nervous system regulation in patients with cirrhosis: a 10-year experience. Henriksen JH; Ring-Larsen H; Christensen NJ Clin Physiol; 1991 Jul; 11(4):293-306. PubMed ID: 1914433 [No Abstract] [Full Text] [Related]